Search

Compugen Ltd

Uždarymo kaina

2.29

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

2.27

Max

2.34

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-65M

-7.7M

Pardavimai

-65M

2.2M

P/E

Sektoriaus vid.

6.263

68.51

Pelnas, tenkantis vienai akcijai

-0.07

Pelno marža

-352.436

Darbuotojai

75

EBITDA

-64M

-7.7M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+119.3% upside

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-45M

225M

Ankstesnė atidarymo kaina

2.29

Ankstesnė uždarymo kaina

2.29

Compugen Ltd Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-06 23:56; UTC

MSCI Inc. shares are higher in after-market trading, gaining since Thursday's close despite earlier pulling back from a session high.

2026-08-06 23:56; UTC

Intercontinental Exchange Inc shares are lower in after-market hours, with no specific news identified to explain the decline. The stock remains above its 20-day moving average.

2026-08-06 23:56; UTC

General Motors Co. shares remain roughly flat in after-market trading. The stock is near the upper end of its one-month range.

2026-08-06 23:56; UTC

KeyCorp shares are modestly higher in after-market trading following Thursday's close, with no specific company news identified to explain the price action.

2026-08-06 23:56; UTC

BWX Technologies shares are higher in after-market hours, following an early spike after the market closed. The stock remains below its 20-day moving average.

2026-08-06 23:56; UTC

Correlated Moves

Lattice Semiconductor is higher in after-market trading, likely influenced by positive momentum in the semiconductor sector and a significant rise in Microchip Technology's stock.

2026-08-06 23:56; UTC

Dycom Industries Inc. is trading higher in after-market hours, reflecting a slight gain since Thursday's close, with no specific news identified.

2026-08-06 23:56; UTC

News

Clear Secure Inc launched a Corporate Memberships program to improve business travel, combining services like CLEAR+ and TSA PreCheck. Shares are trading higher after the announcement.

2026-08-06 23:56; UTC

Tripadvisor Inc shares are higher in after-market trading, reflecting positive sentiment despite broader market challenges. The stock previously peaked before a slight pullback.

2026-08-06 23:56; UTC

Insmed Inc shares are trading lower in after-market hours. No specific news was identified to explain the decline.

2026-08-06 23:56; UTC

Correlated Moves

Entergy Corp shares advanced in after-market trading, reflecting a positive trend in the electric utilities sector amid broader market dynamics.

2026-08-06 23:56; UTC

NRG Energy Inc shares are higher in after-market trading, though no specific news was identified to explain the movement. The stock remains below its 20-day moving average.

2026-08-06 23:56; UTC

News

Shares declined after-hours despite JP Morgan raising price target to $545.

2026-08-06 23:56; UTC

iShares iBoxx $ High Yield Corporate Bond ETF traded roughly flat after market hours, with mixed performance in global equity indices and a stronger U.S. Dollar.

2026-08-06 23:56; UTC

Akebia Therapeutics Inc. shares are higher in after-market trading, advancing modestly since Thursday's close amid routine fluctuations within a narrow range.

2026-08-06 23:56; UTC

Parker-Hannifin Corp shares are higher in after-market hours, recovering from an earlier dip and reflecting a modest uptick since Thursday's close.

2026-08-06 23:56; UTC

Magnite Inc. shares are trading lower in after-market hours, with no specific news identified. The stock remains above its 20-day moving average.

2026-08-06 23:52; UTC

News

First Solar supports Section 232 action on polysilicon imports, benefiting U.S. manufacturing. Shares have moved sharply higher in after-market trading.

2026-08-06 23:51; UTC

Mosaic Co shares traded roughly flat in after-market hours amid a strengthening U.S. Dollar and rising crude oil prices contributing to market volatility.

2026-08-06 23:51; UTC

Correlated Moves

Patrick Industries Inc shares are higher in after-market trading, reflecting positive sector sentiment and following gains in SiteOne Landscape Supply Inc.

2026-08-06 23:51; UTC

VF Corp shares are higher in after-market trading, though no specific news was identified to explain the movement. The stock remains below its 20-day moving average.

2026-08-06 23:51; UTC

Exlservice Holdings Inc shares are higher in after-market trading, continuing a recent upward trend and remaining well above their 20-day moving average.

2026-08-06 23:51; UTC

News

The Invesco Currencyshares Japanese Yen Trust is lower in after-market hours, reflecting broader market movements amid ongoing U.S. and Japan currency interventions.

2026-08-06 23:51; UTC

Ralph Lauren Corp shares are trading lower in after-market hours. The stock saw notable volatility today amid broader market factors, including a stronger U.S. Dollar.

2026-08-06 23:51; UTC

Payoneer Global Inc shares are declining in after-market trading, reversing from earlier gains and remaining below the 20-day moving average.

2026-08-06 23:51; UTC

Conagra Brands Inc shares are higher in after-market hours, reaching a session high and remaining above the 20-day moving average. No specific news was identified.

2026-08-06 23:51; UTC

Alliant Energy Corp shares advanced during after-market hours, reflecting unusual strength despite being below the 20-day moving average and recent declines.

2026-08-06 23:51; UTC

UiPath Inc shares are lower in after-market hours following Thursday's close, despite earlier fluctuations. Broader market dynamics may be influencing the decline.

2026-08-06 23:51; UTC

Greenbrier Companies Inc. shares are lower in after-market trading, continuing a trend of declines over three consecutive sessions amid broader market volatility.

2026-08-06 23:51; UTC

News

LeMaitre Vascular Inc shares declined in after-market trading, nearing the lower end of their one-month range amid broader market volatility from Middle East supply concerns.

Akcijų palyginimas

Kainos pokytis

Compugen Ltd Prognozė

Kainos tikslas

By TipRanks

119.3% į viršų

12 mėnesių prognozė

Vidutinis 5 USD  119.3%

Aukščiausias 6 USD

Žemiausias 4 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Compugen Ltd kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

3 ratings

3

Pirkti

0

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Compugen Ltd

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I monotherapy clinical study in patients with advanced malignancies through sequential dose escalations; Bapotulimab, a therapeutic antibody targeting ILDR2 that is in Phase I clinical study in patients with naïve head and neck squamous cell carcinoma; and Rilvegostomig, a novel anti-TIGIT/PD-1 bispecific antibody, which is in Phase II clinical study in patients with advanced or metastatic non-small cell lung cancer. Its therapeutic pipeline also includes early-stage immuno-oncology programs focused to address various mechanisms of immune resistance; and COM503, high affinity antibody, which blocks the interaction between IL-18 binding protein and IL-18. The company has collaboration agreement with Bayer Pharma AG for the research, development, and commercialization of antibody-based therapeutics against the company's immune checkpoint regulators; Bristol-Myers Squibb to evaluate the safety and tolerability of COM701 in combination with Bristol-Myers Squibb's PD-1 immune checkpoint inhibitor Opdivo in patients with advanced solid tumors; and Johns Hopkins School of Medicine to evaluate novel T cell and myeloid checkpoint targets. It has license agreement with AstraZeneca for the development of bi-specific and multi-specific immuno-oncology antibody products; and research collaboration with Johns Hopkins University for myeloid. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel.
help-icon Live chat